Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Deloitte
Farmers Insurance
Mallinckrodt
Cantor Fitzgerald
Argus Health
QuintilesIMS
McKesson

Generated: April 22, 2018

DrugPatentWatch Database Preview

PRIMAQUINE Drug Profile

« Back to Dashboard

Drug patent expirations by year for PRIMAQUINE
Pharmacology for PRIMAQUINE
Drug ClassAntimalarial
Medical Subject Heading (MeSH) Categories for PRIMAQUINE
Synonyms for PRIMAQUINE
(-)-N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine
(-)-Primaquine
(+-)-8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline phosphate (1:2)
(+)-N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine
(+)-Primaquine
(+/-)-Primaquine
(4-amino-1-methyl-butyl)-(6-methoxy-8-quinolyl)amine;phosphoric acid
013P166
1, N4-(6-methoxy-8-quinolinyl)-
1, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2)
1,4-Pentanediamine, N(4)-(6-methoxy-8-quinolinyl)-
1,4-Pentanediamine, N(sup 4)-(6-methoxy-8-quinolinyl)-, (+-)-, phosphate (1:2)
1,4-Pentanediamine, N(sup 4)-(6-methoxy-8-quinolinyl)-, phosphate (1:2)
1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-
1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)- (9CI)
1,4-pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:1)
1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2)
1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2) (9CI)
1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-(9CI)
3B1-008919
4-22-00-05817 (Beilstein Handbook Reference)
4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine
4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid
4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine;phosphoric acid
4CH-006983
598P906
6-Methoxy-8-((4-amino-1-methylbutyl)amino)quinoline
6-Methoxy-8-(4-amino-1-methylbutylamino)quinoline
6-Methoxy-8-[(4-amino-1-methylbutyl)amino]quinoline
6-Methoxy-8-[4-amino-1-methylbutylamino]quinoline
63-45-6
63-45-6 (1:2 PO4)
66616-84-0
8-?(4-?Amino-?1-?methylbutylamino)?-?6-?methoxyquinoline diphosphate salt
8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline
8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline diphosphate
8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline phosphate (1:2)
8-(4-Amino-1-m
8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline
8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline diphosphate
8-(4-Amino-1-methylbutylamino)-6-methoxyquinolinediphosphate
8-[(4-Amino-1-methylbutyl)amino]-6-methoxyquinoline
90-34-6
90-34-6 (Parent)
A843518
AB00053529
AB00053529_12
AB00053529_14
AB00053529-11
AC-23007
AC1L1J80
AC1L1LVF
AC1L7E8Q
AC1Q4F0C
AC1Q4F4Q
AC1Q6RSO
AC1Q7DLE
AK-51335
AK162158
AKOS005721199
AKOS024462450
AKOS026749962
AN-24192
AN-41858
ANW-50074
API0009074
AS-13148
AX8110977
BB_SC-3079
BBL011330
BDBM71542
bis(phosphoric acid); primaquine
BPBio1_000674
BR-51335
BRN 0019337
BSPBio_000612
BSPBio_002223
C07627
C15H21N3O.2H3O4P
C15H21N3O.2H3PO4
C15H27N3O9P2
CAS-63-45-6
CCG-40283
CCRIS 1946
CCRIS 4109
CHEBI:8405
CHEMBL43128
CHEMBL506
CHEMBL994
cid_359247
CP0101
CPD000875314
CS-3875
CTK8A6939
CTK8B5781
D02126
D08420
D0T1LK
DB01087
DivK1c_000806
dl-Primaquine
DR002818
DSSTox_CID_25248
DSSTox_GSID_45248
DSSTox_RID_80773
DTXSID6045248
DTXSID8023509
EBD11915
EINECS 200-560-8
EINECS 201-987-2
EN300-144245
EN300-51911
Epitope ID:131792
ethylbutylamino)-6-methoxyquinoline
FT-0603262
FT-0687514
GJOHLWZHWQUKAU-UHFFFAOYSA-N
H449
HE054682
HE370156
HMS1569O14
HMS1920J18
HMS2090J17
HMS2092A19
HMS2096O14
HMS2234H13
HMS3259B03
HMS3652B19
HMS502I08
HSDB 6516
HY-12651
I08-0048
IDI1_000806
INDBQLZJXZLFIT-UHFFFAOYSA-N
Kanaprim
Kanaprim (TN)
KBio1_000806
KBio2_001310
KBio2_003878
KBio2_006446
KBio3_001723
KBioGR_000967
KBioSS_001310
KS-00001D0H
LP120268
LS-141312
LS-141315
MCULE-1557087031
MCULE-4488548921
MFCD00598906
MLS001334045
MLS002153831
MolPort-001-794-628
MolPort-003-666-267
MolPort-004-964-068
N-(5-aminopentan-2-yl)-6-methoxyquinolin-8-amine
n-(5-aminopentan-2-yl)-6-methoxyquinolin-8-amine phosphoric acid
N-(5-aminopentan-2-yl)-6-methoxyquinolin-8-amine; bis(phosphoric acid)
N-(5-aminopentan-2-yl)-6-methoxyquinolin-8-amine; phosphoric acid
N(4)-(6-methoxyquinolin-8-yl)pentane-1,4-diamine
N~4~-(6-methoxyquinolin-8-yl)pentane-1,4-diamine
N~4~-[6-(methyloxy)quinolin-8-yl]pentane-1,4-diamine
N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine
N4-(6-methoxy-8-quinolinyl)pentane-1,4-diamine
N4-(6-methoxy-8-quinolinyl)pentane-1,4-diamine;phosphoric acid
N4-(6-methoxy-8-quinolyl)pentane-1,4-diamine
N4-(6-methoxy-8-quinolyl)pentane-1,4-diamine; phosphoric acid
N4-(6-methoxyquinolin-8-yl)pentane-1,4-diamine
N4-(6-Methoxyquinolin-8-yl)pentane-1,4-diamine (2 H3PO4)
N4-(6-Methoxyquinolin-8-yl)pentane-1,4-diamine phosphate
N4-(6-METHOXYQUINOLIN-8-YL)PENTANE-1,4-DIAMINE; BIS(PHOSPHORIC ACID)
N4-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; phosphoric acid
N4-(6-methoxyquinolin-8-yl)pentane-1,4-diamine;phosphoric acid
NC00607
NCGC00016284-01
NCGC00094767-01
NCGC00094767-02
NCGC00178754-01
NCGC00178754-02
NCGC00178754-03
NCGC00178754-06
NCI60_001035
NCI60_005887
NE35433
Neo-Quipenyl
NINDS_000806
NSC 149765
NSC 27296
NSC-149765
NSC-27296
NSC-619961
NSC-757290
NSC149765
NSC27296
NSC619961
NSC757290
Oprea1_546209
Pharmakon1600-01500500
Prestwick_406
Prestwick0_000476
Prestwick1_000476
Prestwick2_000476
Prestwick3_000476
Primachin
Primachina
Primachina [DCIT]
PRIMACHINE PHOSPHATE
Primachinum
Primaquin
Primaquina
Primaquina [INN-Spanish]
Primaquine (Diphosphate)
Primaquine (INN)
Primaquine (TN)
Primaquine [INN:BAN]
Primaquine Bis-Phosphoric Acid
Primaquine bis(phosphate)
Primaquine bisphosphate
Primaquine bisphosphate, 98%
Primaquine bisphosphate, 98% 1g
Primaquine bisphosphate; 8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline diphosphate
primaquine diphosphate
Primaquine diphosphate, European Pharmacopoeia (EP) Reference Standard
PRIMAQUINE DIPHOSPHATE,98%
PRIMAQUINE PHOSPHATE
Primaquine phosphate (JAN/USP)
Primaquine phosphate [USAN]
Primaquine phosphate [USP]
Primaquine phosphate, United States Pharmacopeia (USP) Reference Standard
Primaquine(Diphosphate)
Primaquinediphosphate
Primaquinum
Primaquinum [INN-Latin]
PubChem15391
Quinoline, 8-((4-amino-1-methylbutyl)amino)-6-methoxy-
Quinoline, 8-((4-amino-1-methylbutyl)amino)-6-methoxy-, phosphate (1:2)
Quinoline, 8-(4-amino-1-methylbutylamino)-6-methoxy
Quinoline, 8-(4-amino-1-methylbutylamino)-6-methoxy-
Quinoline, 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-
Quinoline, 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-(6CI,8CI)
S-4508
S. N. 13272
SAM002589929
SBI-0051491.P003
SC-46746
SCHEMBL22207
SCHEMBL41096
SMP1_000263
SMR000875314
SN 13,272
SN 13272
SPBio_000674
SPBio_002551
Spectrum_000830
SPECTRUM1500500
Spectrum2_000887
Spectrum3_000552
Spectrum4_000484
Spectrum5_001363
SR-05000001864
SR-05000001864-7
ST24029985
ST24048764
STL146416
STOCK5S-90838
TG1-296
TG1-297
Tox21_110350
Tox21_110350_1
TR-028405
TX-012465
W9302
WLN: T66 BNJ HO1 JMY1&3Z
WR 2975
Z2791920245

US Patents and Regulatory Information for PRIMAQUINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us PRIMAQUINE primaquine phosphate TABLET;ORAL 008316-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ingenus Pharms Nj PRIMAQUINE PHOSPHATE primaquine phosphate TABLET;ORAL 206043-001 Jun 23, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alvogen Inc PRIMAQUINE PHOSPHATE primaquine phosphate TABLET;ORAL 203924-001 Feb 3, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bayshore Pharms Llc PRIMAQUINE PHOSPHATE primaquine phosphate TABLET;ORAL 204476-001 Feb 25, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health
Chubb
Teva
AstraZeneca
Daiichi Sankyo
Cerilliant
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.